Day-to-day variation of insulin requirements of patients with type 2 diabetes and end-stage renal disease undergoing maintenance hemodialysis

Diabetes Care

Volumn 33, Issue 7, 2010, Pages 1409-1412

  Sobngwi, Eugene ^a,b,c   Enoru, Sostanie ^a   Ashuntantang, Gloria ^a   Azabji Kenfack, Marcel ^a   Dehayem, Mesmin ^b   Onana, Arnold ^a   Biwole, Daniel ^a   Kaze, François ^a   Gautier, Jean François ^d   Mbanya, Jean Claude ^a,b  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b YAOUNDÉ CENTRAL HOSPITAL   (Cameroon)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; ANTIDIABETIC AGENT; UREA;

ADULT; AGED; ARTICLE; BODY SIZE; CALORIE; CLAMP; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE DURATION; GLUCOSE BLOOD LEVEL; HEMODIALYSIS; HUMAN; INJECTION SITE REACTION; INSULIN HYPOGLYCEMIA; INSULIN PUMP; INSULIN TREATMENT; KIDNEY FAILURE; MAINTENANCE THERAPY; MEAL; NON INSULIN DEPENDENT DIABETES MELLITUS; UREA BLOOD LEVEL; BLOOD; CHRONIC KIDNEY FAILURE; CIRCADIAN RHYTHM; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; GLUCOSE CLAMP TECHNIQUE; HYPERGLYCEMIA; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; RENAL REPLACEMENT THERAPY; UREA NITROGEN BLOOD LEVEL;

BLOOD GLUCOSE; BLOOD UREA NITROGEN; CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INFUSIONS, INTRAVENOUS; INSULIN; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; RENAL DIALYSIS; UREA;

EID: 77958160895     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-2176     Document Type: Article

References (16)

1. Atkins RC. The epidemiology of chronic kidney disease. Kidney Int Suppl 2005;94:S14-S18
2. Hager SR. Insulin resistance of uremia. Am J Kidney Dis 1989;14:272-276
3. Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999;104:787-794 (Pubitemid 29536364)
4. Kobayashi S, Maesato K, Moriya H, Ohtake T, Ikeda T. Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis 2005;45:275-280 (Pubitemid 40431052)
5. Amico JA, Klein I. Diabetic management in patients with renal failure. Diabetes Care 1981;4:430-434 (Pubitemid 12201601)
6. Sun CY, Lee CC, Wu MS. Hypoglycemia in diabetic patients undergoing chronic hemodialysis. Ther Apher Dial 2009;13:95-102
7. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986
8. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853
9. Huang CC. Treatment targets for diabetic patients on peritoneal dialysis: any evidence? Perit Dial Int 2007;27(Suppl. 2):S176-S179
10. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004;79:992-1000
11. Oomichi T, Emoto M, Tabata T, Morioka T, Tsujimoto Y, Tahara H, Shoji T, Nishizawa Y. Impact of glycemic control on survival of diabetic patients on chronic regular hemodialysis: a 7-year observational study. Diabetes Care 2006;29:1496-500 (Pubitemid 44127570)
12. Zoungas S, Kerr PG, Lui M, Teede HJ. The impact of glycaemic control on outcomes in patients with end-stage renal disease and type 2 diabetes. Nephrology (Carlton) 2008;13:124-127 (Pubitemid 351229629)
13. American Diabetes Association. Standards of medical care in diabetes: 2009. Diabetes Care 2009;32(Suppl. 1):S13-S61
14. Schmitz O. Insulin-mediated glucose uptake in nondialyzed and dialyzed uremic insulin-dependent diabetic subjects. Diabetes 1985;34:1152-1159
15. DeFronzo RA, Tobin JD, Rowe JW, Andres R. Glucose intolerance in uremia: quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin. J Clin Invest 1978;62:425-435
16. Kobayashi S, Maejima S, Ikeda T, Nagase M. Impact of dialysis therapy on insulin resistance in end-stage renal disease: comparison of haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2000;15:65-70